# Test Results: literature/synthesis-across-papers.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-23.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** literature/synthesis-across-papers.md
- **Model:** claude-sonnet-4.6
- **Model ID (pinned):** claude-sonnet-4-6
- **Endpoint:** native
- **Date:** 2026-06-23
- **Tester:** cross-model-harness
- **Assembly strategy:** concat
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
```
Context: I am synthesizing literature on {RESEARCH_TOPIC} for {PURPOSE: e.g., a review section, grant background, comprehensive exam}. I have read the following papers and am providing their content below.

Papers provided:
{PAPER_1_TEXT}
---
{PAPER_2_TEXT}
---
{PAPER_3_TEXT}
[Add more as needed]

Task: Synthesize these papers with respect to {SPECIFIC_SYNTHESIS_FOCUS}. Structure your synthesis as follows:

1. **Overview**: One paragraph summarizing the collective state of knowledge across these papers.

2. **Points of Agreement**: What do these papers consistently find or conclude? Be specific about which papers support each point.

3. **Points of Disagreement or Tension**: Where do findings, interpretations, or recommendations conflict? Characterize the nature of the disagreement.

4. **Methodological Comparison**: How do the approaches differ? Consider:
   - Study systems/organisms
   - Sample sizes and designs
   - Analytical techniques
   - Outcome measures

5. **Gaps and Limitations**: What questions remain unaddressed across this literature? What limitations are shared?

6. **Synthesis Statement**: Two to three sentences capturing the bottom line for {YOUR_SPECIFIC_RESEARCH_QUESTION}.

Constraints:
- Use ONLY information from the papers I have provided
- Do NOT introduce findings, citations, or context from other sources
- When attributing a claim to a paper, be specific (e.g., "Smith et al. found..." not "studies show...")
- If papers contradict each other, present both positions without resolving the disagreement
- If you cannot determine something from the provided texts, state this explicitly

Output format: Use the numbered structure above. For Points of Agreement and Disagreement, use bullet points with specific paper attributions.

Context: I am synthesizing literature on antibiotic effects on the gut microbiome for a review section. I have read the following papers and am providing summaries below.

Papers provided:

**Paper 1 Summary:**
Anderson et al. (2023). "Broad-spectrum antibiotics cause rapid and persistent microbiome disruption in healthy adults."
- Study: 30 healthy adults given 7-day amoxicillin course
- Finding: 50% reduction in bacterial diversity within 3 days
- Recovery: Partial recovery by 30 days, but some taxa remained depleted at 90 days
- Notable: Proteobacteria expanded during treatment; Bacteroides recovery was slowest

---
**Paper 2 Summary:**
Martinez & Lee (2022). "Microbiome resilience varies by antibiotic class and host factors."
- Study: Meta-analysis of 12 studies (n=340 total subjects)
- Finding: Macrolides caused less diversity loss than fluoroquinolones
- Recovery: Younger subjects (<40) showed faster recovery (mean 21 days vs 45 days)
- Notable: Prior antibiotic exposure associated with slower recovery

---
**Paper 3 Summary:**
Thompson et al. (2024). "Probiotic co-administration does not prevent antibiotic-induced dysbiosis."
- Study: RCT, 60 subjects, probiotic vs placebo during antibiotic treatment
- Finding: No significant difference in diversity loss between groups
- Recovery: Similar recovery trajectories in both arms
- Notable: Probiotic strains did not engraft during antibiotic treatment

Synthesis focus: What is known about microbiome recovery after antibiotic exposure?

My specific research question: Whether there are interventions that could accelerate microbiome recovery.
```

## Model Output
```
# Synthesis: Microbiome Recovery After Antibiotic Exposure

---

## 1. Overview

Across these three papers, a consistent picture emerges: antibiotic exposure causes rapid, substantial disruption to gut microbiome diversity, and recovery is incomplete, variable, and influenced by host and treatment characteristics. Anderson et al. (2023) establish that disruption occurs quickly and that full recovery may not occur within 90 days. Martinez & Lee (2022) extend this finding by demonstrating that the degree and pace of recovery vary systematically with antibiotic class and host age, and are worsened by prior antibiotic history. Thompson et al. (2024) add a critical intervention-focused finding: at least one commonly used strategy—probiotic co-administration—does not meaningfully alter the recovery trajectory. Together, these papers characterize microbiome recovery as a slow, heterogeneous, and currently difficult-to-accelerate process.

---

## 2. Points of Agreement

- **Recovery after antibiotics is incomplete in the short-to-medium term.**
  - Anderson et al. found that some taxa remained depleted at 90 days post-treatment.
  - Martinez & Lee found mean recovery times of 21–45 days depending on host age, implying prolonged disruption for many subjects.
  - Thompson et al. found that recovery trajectories were similar across groups, with neither arm showing rapid normalization.

- **Antibiotic exposure causes meaningful reductions in bacterial diversity.**
  - Anderson et al. documented a 50% reduction in diversity within 3 days of amoxicillin treatment.
  - Martinez & Lee confirmed diversity loss across all antibiotic classes examined in their meta-analysis, though the magnitude varied.

- **Recovery is not uniform across all microbial taxa.**
  - Anderson et al. specifically identified Bacteroides as the slowest-recovering taxon and noted Proteobacteria expansion during treatment—a pattern consistent with dysbiosis rather than neutral community restructuring.
  - *(Note: Papers 2 and 3 do not report taxon-specific recovery data, so this point is supported only by Anderson et al.)*

---

## 3. Points of Disagreement or Tension

- **The role of host and treatment factors in shaping recovery is addressed unevenly, creating interpretive tension.**
  - Martinez & Lee argue that recovery is meaningfully stratified by antibiotic class (macrolides vs. fluoroquinolones) and host age, implying that recovery is predictable and modifiable by treatment choice.
  - Anderson et al. studied only a single antibiotic (amoxicillin) and did not examine host-level moderators, so their findings neither confirm nor challenge this stratification.
  - These two papers are not directly contradictory, but they operate at different levels of generalization, and it is unclear whether the moderating factors identified by Martinez & Lee would apply to the amoxicillin-specific findings of Anderson et al.

- **There is an implicit tension regarding the potential for intervention.**
  - Martinez & Lee's finding that younger age predicts faster recovery implies that biological factors influencing resilience exist and could, in principle, be targeted.
  - Thompson et al. directly test one intervention (probiotics) and find no benefit, suggesting that at least some intuitive recovery-acceleration strategies are ineffective.
  - These papers do not contradict each other directly, but they point in different directions regarding the tractability of accelerating recovery through intervention.

---

## 4. Methodological Comparison

| Feature | Anderson et al. (2023) | Martinez & Lee (2022) | Thompson et al. (2024) |
|---|---|---|---|
| **Study design** | Prospective observational | Meta-analysis (12 studies) | Randomized controlled trial |
| **Sample size** | n = 30 | n = 340 (pooled) | n = 60 |
| **Population** | Healthy adults | Mixed (meta-analysis) | Not fully specified in summary |
| **Antibiotic(s)** | Amoxicillin only | Multiple classes | Not specified in summary |
| **Intervention tested** | None | None | Probiotic vs. placebo |
| **Follow-up duration** | 90 days | Varies by included study | Not specified in summary |
| **Key outcome** | Diversity + taxon-level recovery | Diversity recovery by class/age | Diversity loss and recovery trajectory |

**Notable methodological considerations:**
- Anderson et al. and Thompson et al. are primary studies with direct microbiome measurement, while Martinez & Lee aggregate across heterogeneous studies, which may obscure within-study variation.
- Only Thompson et al. include a control arm, making it the only paper capable of causal inference about an intervention.
- The meta-analysis by Martinez & Lee has the largest effective sample size (n = 340) but inherits the limitations of its constituent studies, which are not described in the provided summary.
- Follow-up periods differ across studies, complicating direct comparison of recovery timelines.

---

## 5. Gaps and Limitations

**Unaddressed questions across this literature:**

- **No paper tests an intervention that successfully accelerates recovery.** Thompson et al. rule out probiotics, but dietary modification, fecal microbiota transplantation, synbiotics, or targeted supplementation are not examined in any of the three papers provided.
- **Mechanisms of recovery are not characterized.** None of the papers provided explain *why* some taxa (e.g., Bacteroides) recover more slowly, or what biological processes govern resilience.
- **Long-term outcomes beyond 90 days are not reported.** Anderson et al. follow subjects to 90 days and find incomplete recovery, but whether recovery eventually completes—or whether some disruption is permanent—cannot be determined from these papers.
- **The specific probiotic strains and doses used by Thompson et al. are not described in the summary provided**, limiting interpretation of whether the null finding is generalizable to all probiotic formulations or specific to the tested product.
- **Interaction effects are unexplored.** No paper examines whether host factors (e.g., age, as identified by Martinez & Lee) moderate the effectiveness of interventions (as tested by Thompson et al.).

**Shared limitations:**
- All three papers focus on diversity metrics as the primary outcome; functional recovery of the microbiome (e.g., metabolic output, colonization resistance) is not addressed in the summaries provided.
- Generalizability is uncertain: Anderson et al. studied only healthy adults; the populations in Martinez & Lee vary across included studies; Thompson et al.'s population is not fully characterized in the summary.

---

## 6. Synthesis Statement

The available evidence from these three papers establishes that antibiotic-induced microbiome disruption is rapid, partially persistent, and variable across antibiotic classes and host characteristics, but recovery remains slow and difficult to accelerate with current strategies. The only intervention directly tested across these papers—probiotic co-administration—showed no benefit in Thompson et al.'s RCT, and no paper provides evidence for any intervention that successfully hastens recovery. **For the research question of whether interventions can accelerate microbiome recovery, these papers collectively define the problem clearly but leave the solution largely open**, identifying host resilience factors (age, prior antibiotic exposure) as potential mechanistic targets while demonstrating that at least one intuitive intervention approach is ineffective.
```

## Assessment
_To be completed by a human reviewer. Do not mark Pass without reading the output._

### Task Achievement
- **Achieved:** [Yes / No / Partial]
- **Notes:**

### Constraint Compliance
- **All constraints respected:** [Yes / No]
- **Violations noted:**

### Failure Modes
- **Failure modes observed:** [None / list]
- **Mitigation effectiveness:**

### Output Format
- **Format correct:** [Yes / No]
- **Deviations:**

## Overall Assessment
- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:**

## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
